Schris: I don't really believe anything has changed. I just believe that the market is taking a little more realistic look at SGLB's immediate prospects. Unfortunately, since the Board meeting there has been further dilution and no contract awards. I sold all my shares at .18 and have been on the sidelines since that time, but watching closely. Mark stated at the meeting that both the printing and dental products were in an evaluation status by both potential distributors and end users. He cautioned that the evaluations would take some time before orders could be expected. The sense I came away with was that the earliest that this could happen was this spring /early summer. While Mark and the Board are extremely impressive academics/researchers there was no one in the entire company with a marketing/sales/distribution background. There also were no independent directors, which bothered me some. I asked when they planned to bring on an independent director with a solid business background and I was assured that it was already in process. Sure enough an appointment was announced within weeks of the Board meeting. I really like these guys and want to see them succeed but you have to understand that they are extremely thinly staffed and are totally dependent upon potential distibutors to carry the full weight of sales, distribution, marketing, etc. I believe the stock will be range-bound at best until solid revenue generating contracts are announced. Of course, I could be totally wrong, but that is how I'm basing my investment decisions.
News 
Market Data 
Discover 
